TBPH
Theravance Biopharma Inc.
$14.07
+$0.19(+1.37%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$698.51M
Volume
377.75K
52W Range
$7.88 - $14.55
Target Price
$20.00
Key Metrics Overview
| Market Cap | $698.51M | P/E Ratio | N/A |
| 52W High | $14.55 | 52W Low | $7.88 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 26.3% | 52W Position | 92.8% |
| Overall Score | 66 | Value Score | -- |
| Quality Score | -- | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-0.46 | EPS Next Est | $-0.69 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TBPH | $14.07 | +1.4% | 377.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Theravance Biopharma Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW